investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of ASXL1 mutations in myeloid malignancies
Omar Abdel-Wahab
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Yves Pommier
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Leukaemia
Markus Muschen
Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia
Leukaemia
George A Calin
Protein-coding and non-coding RNA biomarkers for early detection of CLL
Leukaemia
Edward W Harhaj
Mechanisms of HTLV-I Tax Mediated NF-kB Activation
Leukaemia
Pathology
Hematology and hematologic malignancies
Effie W Petersdorf
Clinical Significance of MHC Haplotypes in HCT
Leukaemia
Robert K Bradley
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
Leukaemia
Robert G Roeder
Function and targeting of a stable transcription factor complex in leukemia
Leukaemia
Marc Nicklaus
In Silico Screening for Cancer Targets
Leukaemia
Pathology
Hematology and hematologic malignancies
Amy Paguirigan
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Leukaemia